EnBiotix
11 articles about EnBiotix
-
The problem Kinaset is trying to solve is that over time, patients receiving asthma therapies – typically inhaled corticosteroids plus bronchodilators – become steroid-refractory.
-
Polyphor to Inform about the Financing of its Merger Partner EnBiotix
12/29/2021
Polyphor AG and EnBiotix Inc. announced that EnBiotix has completed a convertible debenture raise of USD 11 million to finance its future operations.
-
EnBiotix, Inc. Closes $11M Pre-Merger Financing
12/29/2021
EnBiotix, Inc., a rare disease company currently focused on chronic respiratory disorders, announced the closing of an $11M pre-merger, convertible note round of financing comprised of Vectura Group plc, the Cystic Fibrosis Foundation and Sanford Biosciences LLC.
-
Polyphor and EnBiotix Announce Dosing of First Patient in a First-in-Human Clinical Trial of Inhaled Murepavadin
12/15/2021
Polyphor AG and EnBiotix Inc. announced that the first subjects have been dosed in the first-in-human Phase I trial of a novel-class antibiotic murepavadin, delivered via the oral inhalation route.
-
Polyphor and EnBiotix Announce Signing of Merger Agreement and Sale of Inhaled Murepavadin to EnBiotix
9/1/2021
Polyphor and EnBiotix Inc. announced that the companies have signed a merger agreement pursuant to which Polyphor acquires all of the outstanding capital stock of EnBiotix in exchange for shares of Polyphor common stock.
-
EnBiotix Reports Publication Highlighting Anti-Persister Agent Targeting Antibiotic-Tolerant Infections In Antimicrobial Agents And Chemotherapy
10/2/2017
-
EnBiotix Acquires Anti-Microbial Peptide Portfolio From AMP Therapeutics GmbH
11/3/2016
-
Elanco, EnBiotix Establish Collaboration Exploring Engineered Phage Technology
6/16/2016
-
EnBiotix To Collaborate With Mayo Clinic On Engineered Phage Program
6/13/2016
-
EnBiotix Receives Grand Challenges Explorations Grant For Groundbreaking Research In Global Health And Development
5/27/2016
-
EnBiotix Closes Series A Financing; Forms EnBiotix (Brasil) Ltda. in Deal with Wired Holdings
5/12/2016